SurModics (SRDX) Tops Q3 EPS by 98c, beats revenue

SurModics (NASDAQ: SRDX) reported Q3 EPS of $0.52, $0.98 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $52.5 million versus the consensus estimate of $26.27 million.

For earnings history and earnings-related data on SurModics (SRDX) click here.

You May Also Be Interested In

• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in
• Deutsche Bank Reiterates Buy Rating on Redcare Pharmacy NV (RDC:GR)